Dr. Martens (LON:DOCS) Trading Down 0.3% - Here's What Happened

Dr. Martens plc (LON:DOCS - Get Free Report) fell 0.3% during trading on Monday . The stock traded as low as GBX 76.85 ($1.03) and last traded at GBX 77.70 ($1.04). 530,409 shares traded hands during trading, a decline of 74% from the average session volume of 2,016,915 shares. The stock had previously closed at GBX 77.90 ($1.05).

Wall Street Analysts Forecast Growth

DOCS has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. Royal Bank Of Canada decreased their price objective on shares of Dr. Martens from GBX 7,000 ($94.14) to GBX 6,000 ($80.69) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.

Dr. Martens Stock Performance

The company has a market capitalization of £746.52 million, a PE ratio of 10.90, a P/E/G ratio of 6.40 and a beta of 0.11. The stock's 50-day simple moving average is GBX 76.24 and its 200 day simple moving average is GBX 65.16. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.

Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, research analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.